User menu

Vancomycin population pharmacokinetics during extracorporeal membrane oxygenation therapy: A matched cohort study

Bibliographic reference Donadello, K. ; Roberts, J.A. ; Cristallini, S. ; Beumier, M. ; Shekar, K. ; et. al. Vancomycin population pharmacokinetics during extracorporeal membrane oxygenation therapy: A matched cohort study. In: Critical Care, Vol. 18, no.6, p. 632 (2014)
Permanent URL
  1. MacLaren Graeme, Combes Alain, Bartlett Robert H., Contemporary extracorporeal membrane oxygenation for adult respiratory failure: life support in the new era, 10.1007/s00134-011-2439-2
  2. Peek Giles J, Mugford Miranda, Tiruvoipati Ravindranath, Wilson Andrew, Allen Elizabeth, Thalanany Mariamma M, Hibbert Clare L, Truesdale Ann, Clemens Felicity, Cooper Nicola, Firmin Richard K, Elbourne Diana, Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial, 10.1016/s0140-6736(09)61069-2
  3. Shekar Kiran, Roberts Jason A, Welch Susan, Buscher Hergen, Rudham Sam, Burrows Fay, Ghassabian Sussan, Wallis Steven C, Levkovich Bianca, Pellegrino Vin, McGuinness Shay, Parke Rachael, Gilder Eileen, Barnett Adrian G, Walsham James, Mullany Daniel V, Fung Yoke L, Smith Maree T, Fraser John F, ASAP ECMO: Antibiotic, Sedative and Analgesic Pharmacokinetics during Extracorporeal Membrane Oxygenation: a multi-centre study to optimise drug therapy during ECMO, 10.1186/1471-2253-12-29
  4. Roberts Darren M., Roberts Jason A., Roberts Michael S., Liu Xin, Nair Priya, Cole Louise, Lipman Jeffrey, Bellomo Rinaldo, Variability of antibiotic concentrations in critically ill patients receiving continuous renal replacement therapy : A multicentre pharmacokinetic study*, 10.1097/ccm.0b013e318241e553
  5. Udy Andrew A., Varghese Julie M., Altukroni Mahdi, Briscoe Scott, McWhinney Brett C., Ungerer Jacobus P., Lipman Jeffrey, Roberts Jason A., Subtherapeutic Initial β-Lactam Concentrations in Select Critically Ill Patients, 10.1378/chest.11-1671
  6. Taccone Fabio Silvio, Laterre Pierre-François, Dugernier Thierry, Spapen Herbert, Delattre Isabelle, Witebolle Xavier, De Backer Daniel, Layeux Brice, Wallemacq Pierre, Vincent Jean-Louis, Jacobs Frédérique, Insufficient β-lactam concentrations in the early phase of severe sepsis and septic shock, 10.1186/cc9091
  7. Shekar Kiran, Fraser John F., Smith Maree T., Roberts Jason A., Pharmacokinetic changes in patients receiving extracorporeal membrane oxygenation, 10.1016/j.jcrc.2012.02.013
  8. Shekar K, Roberts JA, Mullany DV, Corley A, Fisquet S, Bull TN, Barnett AG, Fraser JF: Increased sedation requirements in patients receiving extracorporeal membrane oxygenation for respiratory and cardio-respiratory failure. Anaesth Intensive Care. 2012, 40: 648-655.
  9. Shekar Kiran, Roberts Jason A, Mcdonald Charles I, Fisquet Stephanie, Barnett Adrian G, Mullany Daniel V, Ghassabian Sussan, Wallis Steven C, Fung Yoke L, Smith Maree T, Fraser John F, Sequestration of drugs in the circuit may lead to therapeutic failure during extracorporeal membrane oxygenation, 10.1186/cc11679
  10. Rybak Michael J., Lomaestro Ben M., Rotschafer John C., Moellering Robert C., Craig Willam A., Billeter Marianne, Dalovisio Joseph R., Levine Donald P., Vancomycin Therapeutic Guidelines: A Summary of Consensus Recommendations from the Infectious Diseases Society of America, the American Society of Health‐System Pharmacists, and the Society of Infectious Diseases Pharmacists, 10.1086/600877
  11. Wysocki M., Delatour F., Faurisson F., Rauss A., Pean Y., Misset B., Thomas F., Timsit J.-F., Similowski T., Mentec H., Mier L., Dreyfuss D., Continuous versus Intermittent Infusion of Vancomycin in Severe Staphylococcal Infections: Prospective Multicenter Randomized Study, 10.1128/aac.45.9.2460-2467.2001
  12. Kielstein Jan T., Heiden Anna Maria, Beutel Gernot, Gottlieb Jens, Wiesner Olaf, Hafer Carsten, Hadem Johannes, Reising Ansgar, Haverich Axel, Kühn Christian, Fischer Stefan, Renal function and survival in 200 patients undergoing ECMO therapy, 10.1093/ndt/gfs398
  13. Cianferoni S., Devigili A., Ocampos-Martinez E., Penaccini L., Scolletta S., Abdelhadii A., De Backer D., Beumier M., Jacobs F., Vincent J.-L., Taccone F. S., Development of acute kidney injury during continuous infusion of vancomycin in septic patients, 10.1007/s15010-013-0460-9
  14. Wilson F. Perry, Berns Jeffrey S., Vancomycin levels are frequently subtherapeutic during continuous venovenous hemodialysis (CVVHD), 10.5414/cn106993
  15. Mulla Hussain, Pooboni Suneel, Population pharmacokinetics of vancomycin in patients receiving extracorporeal membrane oxygenation, 10.1111/j.1365-2125.2005.02432.x
  16. Ocampos-Martinez Eva, Penaccini Laura, Scolletta Sabino, Abdelhadii Ali, Devigili Alessandro, Cianferoni Silvia, de Backer Daniel, Jacobs Frédérique, Cotton Frédéric, Vincent Jean-Louis, Taccone Fabio Silvio, Determinants of early inadequate vancomycin concentrations during continuous infusion in septic patients, 10.1016/j.ijantimicag.2011.12.008
  17. Covajes Cecilia, Scolletta Sabino, Penaccini Laura, Ocampos-Martinez Eva, Abdelhadii Ali, Beumier Marjorie, Jacobs Frédérique, de Backer Daniel, Vincent Jean-Louis, Taccone Fabio Silvio, Continuous infusion of vancomycin in septic patients receiving continuous renal replacement therapy, 10.1016/j.ijantimicag.2012.10.018
  18. Roberts J. A., Taccone F. S., Udy A. A., Vincent J.-L., Jacobs F., Lipman J., Vancomycin Dosing in Critically Ill Patients: Robust Methods for Improved Continuous-Infusion Regimens, 10.1128/aac.01708-10
  19. KNAUS WILLIAM A., DRAPER ELIZABETH A., WAGNER DOUGLAS P., ZIMMERMAN JACK E., APACHE II : A severity of disease classification system, 10.1097/00003246-198510000-00009
  20. Vincent J. -L., Moreno R., Takala J., Willatts S., De Mendonça A., Bruining H., Reinhart C. K., Suter P. M., Thijs L. G., The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure : On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine (see contributors to the project in the appendix), 10.1007/bf01709751
  21. Beal SL, Sheiner LB, Boeckmann AJ, Bauer RJ: Introduction to NONMEM 7.2.0. NONMEM 7.2.0 users guides. 1989-2011, Icon Development Solutions, Ellicott City, Maryland, USA
  22. Wings for NONMEN. [], [ ]
  23. Parke John, Holford Nicholas H.G., Charles Bruce G., A procedure for generating bootstrap samples for the validation of nonlinear mixed-effects population models, 10.1016/s0169-2607(98)00098-4
  24. Buck Marcia L, Pharmacokinetic Changes During Extracorporeal Membrane Oxygenation : Implications for Drug Therapy of Neonates, 10.2165/00003088-200342050-00001
  25. Bhatt-Mehta V, Johnson CE, Schumacher RE: Gentamicin pharmacokinetics in term neonates receiving extracorporeal membrane oxygenation. Pharmacotherapy. 1992, 12: 28-32.
  26. Alcorn Jane, McNamara Patrick J., Pharmacokinetics in the newborn, 10.1016/s0169-409x(03)00030-9
  27. Amaker RD, DiPiro JT, Bhatia J: Pharmacokinetics of vancomycin in critically ill infants undergoing extracorporeal membrane oxygenation. Antimicrob Agents Chemother. 1996, 40: 1139-1142.
  28. Roberts Jason A., Lipman Jeffrey, Pharmacokinetic issues for antibiotics in the critically ill patient : , 10.1097/ccm.0b013e3181961bff
  29. Shekar Kiran, Fraser John F, Taccone Fabio Silvio, Welch Susan, Wallis Steven C, Mullany Daniel V, Lipman Jeffrey, Roberts Jason A, The combined effects of extracorporeal membrane oxygenation and renal replacement therapy on meropenem pharmacokinetics: a matched cohort study, 10.1186/s13054-014-0565-2
  30. Mulla H, Peek GJ, Harvey C, Westrope C, Kidy Z, Ramaiah R: Oseltamivir pharmacokinetics in critically ill adults receiving extracorporeal membrane oxygenation support. Anaesth Intensive Care. 2013, 41: 66-73.
  31. Graulich Johannes, Walzog Barbara, Marcinkowski Monika, Bauer Karl, Kössel Hans, Fuhrmann Gesa, Bührer Christoph, Gaehtgens Peter, Versmold Hans T, Leukocyte and Endothelial Activation in a Laboratory Model of Extracorporeal Membrane Oxygenation (ECMO), 10.1203/00006450-200011000-00021
  32. Frazee Erin N, Rule Andrew D, Herrmann Sandra M, Kashani Kianoush B, Leung Nelson, Virk Abinash, Voskoboev Nikolay, Lieske John C, Serum cystatin C predicts vancomycin trough levels better than serum creatinine in hospitalized patients: a cohort study, 10.1186/cc13899
  33. Berthoin Karine, Ampe Els, Tulkens Paul M., Carryn Stephane, Correlation between free and total vancomycin serum concentrations in patients treated for Gram-positive infections, 10.1016/j.ijantimicag.2009.08.005
  34. van Hal S. J., Lodise T. P., Paterson D. L., The Clinical Significance of Vancomycin Minimum Inhibitory Concentration in Staphylococcus aureus Infections: A Systematic Review and Meta-analysis, 10.1093/cid/cir935
  35. Cataldo M. A., Tacconelli E., Grilli E., Pea F., Petrosillo N., Continuous versus intermittent infusion of vancomycin for the treatment of Gram-positive infections: systematic review and meta-analysis, 10.1093/jac/dkr442